Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
26.03. | Recce Pharmaceuticals - R&D advance (A$11.18m) extends runway | 132 | Edison Investment Research | Recce Pharmaceuticals recently received A$11.18m as an R&D advance credit through an arrangement with Endpoints Capital for the R&D tax credit rebates that Recce expects to receive for FY23/FY24 and... ► Artikel lesen | |
26.03. | Immix Biopharma - Marching towards US clinical trials for NXC-201 | 254 | Edison Investment Research | Immix Biopharma is closer to dosing its first US patient for lead CAR-T asset NXC-201, with the appointment of the Memorial Sloan Kettering Cancer Center as the main clinical site for the company's... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 331 |
EVOTEC | 299 |
TUI | 212 |
NVIDIA | 179 |
DEUTSCHE BANK | 172 |
BAYER | 160 |
PLUG POWER | 145 |
NEL | 136 |
RHEINMETALL | 135 |
SIEMENS ENERGY | 112 |
BARRICK GOLD | 111 |
COMMERZBANK | 108 |
BASF | 106 |
TESLA | 105 |
VOLKSWAGEN | 95 |
RWE | 93 |
BYD | 89 |
DEUTSCHE LUFTHANSA | 86 |
ALLIANZ | 85 |
RENK GROUP | 81 |
MERCEDES-BENZ | 79 |
DEUTSCHE TELEKOM | 78 |
HEIDELBERGER DRUCK | 76 |
AIXTRON SE | 74 |
ALIBABA | 73 |